Annual EBITDA
-$22.73 M
+$17.26 M+43.16%
December 31, 2023
Summary
- As of February 10, 2025, LABP annual EBITDA is -$22.73 million, with the most recent change of +$17.26 million (+43.16%) on December 31, 2023.
- During the last 3 years, LABP annual EBITDA has risen by +$7.81 million (+25.58%).
Performance
LABP EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly EBITDA
-$9.29 M
-$2.69 M-40.62%
March 31, 2024
Summary
- As of February 10, 2025, LABP quarterly EBITDA is -$9.29 million, with the most recent change of -$2.69 million (-40.62%) on March 31, 2024.
- Over the past year, LABP quarterly EBITDA has dropped by -$4.10 million (-78.78%).
Performance
LABP Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM EBITDA
-$25.54 M
-$2.82 M-12.39%
March 31, 2024
Summary
- As of February 10, 2025, LABP TTM EBITDA is -$25.54 million, with the most recent change of -$2.82 million (-12.39%) on March 31, 2024.
- Over the past year, LABP TTM EBITDA has dropped by -$2.91 million (-12.87%).
Performance
LABP TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
LABP EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +43.2% | -78.8% | -12.9% |
| 3 y3 years | +25.6% | +5.7% | +26.3% |
| 5 y5 years | -281.3% | -167.1% | -634.0% |
LABP EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +75.9% | +109.4% | +118.8% | +12.9% | +128.4% |
| 5 y | 5-year | +74.0% | +75.9% | -336.4% | +118.8% | +634.0% | +128.4% |
| alltime | all time | +281.3% | +75.9% | -336.4% | +118.8% | +634.0% | +128.4% |
Landos Biopharma EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2024 | - | -$9.29 M(+40.6%) | -$25.54 M(+12.4%) |
| Dec 2023 | -$22.73 M(-43.2%) | -$6.61 M(+27.1%) | -$22.73 M(+0.4%) |
| Sep 2023 | - | -$5.20 M(+17.1%) | -$22.63 M(-10.4%) |
| Jun 2023 | - | -$4.44 M(-31.5%) | -$25.26 M(-20.7%) |
| Mar 2023 | - | -$6.48 M(-0.5%) | -$31.86 M(-20.3%) |
| Dec 2022 | -$39.98 M(+3.5%) | -$6.51 M(-16.8%) | -$39.98 M(-25.7%) |
| Sep 2022 | - | -$7.83 M(-29.1%) | -$53.81 M(-7.8%) |
| Jun 2022 | - | -$11.04 M(-24.4%) | -$58.34 M(+34.5%) |
| Mar 2022 | - | -$14.60 M(-28.2%) | -$43.36 M(+12.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$38.62 M(+26.5%) | -$20.34 M(+64.6%) | -$38.62 M(+30.3%) |
| Sep 2021 | - | -$12.36 M(-414.2%) | -$29.64 M(+15.5%) |
| Jun 2021 | - | $3.93 M(-139.9%) | -$25.67 M(-25.9%) |
| Mar 2021 | - | -$9.86 M(-13.3%) | -$34.66 M(+13.4%) |
| Dec 2020 | -$30.54 M(+133.8%) | -$11.36 M(+35.6%) | -$30.56 M(+34.8%) |
| Sep 2020 | - | -$8.38 M(+66.0%) | -$22.68 M(+58.6%) |
| Jun 2020 | - | -$5.05 M(-12.4%) | -$14.30 M(+54.6%) |
| Mar 2020 | - | -$5.77 M(+65.7%) | -$9.25 M(+165.7%) |
| Dec 2019 | -$13.06 M(+119.1%) | -$3.48 M | -$3.48 M |
| Dec 2018 | -$5.96 M | - | - |
FAQ
- What is Landos Biopharma annual EBITDA?
- What is the all time high annual EBITDA for Landos Biopharma?
- What is Landos Biopharma annual EBITDA year-on-year change?
- What is Landos Biopharma quarterly EBITDA?
- What is the all time high quarterly EBITDA for Landos Biopharma?
- What is Landos Biopharma quarterly EBITDA year-on-year change?
- What is Landos Biopharma TTM EBITDA?
- What is the all time high TTM EBITDA for Landos Biopharma?
- What is Landos Biopharma TTM EBITDA year-on-year change?
What is Landos Biopharma annual EBITDA?
The current annual EBITDA of LABP is -$22.73 M
What is the all time high annual EBITDA for Landos Biopharma?
Landos Biopharma all-time high annual EBITDA is -$5.96 M
What is Landos Biopharma annual EBITDA year-on-year change?
Over the past year, LABP annual EBITDA has changed by +$17.26 M (+43.16%)
What is Landos Biopharma quarterly EBITDA?
The current quarterly EBITDA of LABP is -$9.29 M
What is the all time high quarterly EBITDA for Landos Biopharma?
Landos Biopharma all-time high quarterly EBITDA is $3.93 M
What is Landos Biopharma quarterly EBITDA year-on-year change?
Over the past year, LABP quarterly EBITDA has changed by -$4.10 M (-78.78%)
What is Landos Biopharma TTM EBITDA?
The current TTM EBITDA of LABP is -$25.54 M
What is the all time high TTM EBITDA for Landos Biopharma?
Landos Biopharma all-time high TTM EBITDA is -$3.48 M
What is Landos Biopharma TTM EBITDA year-on-year change?
Over the past year, LABP TTM EBITDA has changed by -$2.91 M (-12.87%)